Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly presented awards to four outstanding leaders in T1D research whose impact has pushed Breakthrough ...
Loraine and Natalie Brogan share their type 1 diabetes story and what research and the Participant Advisory Council mean to ...
Pat McAleer raises his fist in celebration after reaching the Atlantic Ocean at Virginia Beach, VA. On July 15, Pat McAleer flew from Richmond, VA, to Seattle, WA, dipped his bike in the Pacific Ocean ...
On March 6, 2027, the Breakthrough T1D community will gather at San Francisco City Hall for the 28th Annual San Francisco Gala. This year’s Impact Award goes to Betsy and Dan Wright, in recognition of ...
Disease-modifying therapies (DMTs) are treatments that prevent, slow, or reverse type 1 diabetes (T1D) by preserving or restoring insulin-producing beta cells. While there are several DMTs in clinical ...
“Unannounced Meals” Functionality Would Provide Significant Quality-of-Life Improvements for People Living with Type 1 Diabetes PALO ALTO, Calif., Oct. 22, 2026—Tidepool, a non-profit leader advancing ...
Hey Walker! We’re so excited to see you on October 25th 🙂 Check out the links below for important information: ...
A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.
A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon Pharmaceuticals’ investigational immunosuppression therapy tegoprubart in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results